150
Participants
Start Date
April 5, 2019
Primary Completion Date
May 29, 2023
Study Completion Date
May 29, 2023
Valganciclovir
"Valganciclovir is a L-valyl ester of ganciclovir that exists as a mix of 2 diastereomers. After administration, both are converted to ganciclovir by esterases. Ganciclovir is a synthetic analogue of 2'-deoxyguanosine, it inhibits replication of cytomegalovirus.~In CMV-infected cells it's phosphorylated (phosphorylation is dependent on the viral kinase and occurs preferentially in virus-infected cells). Ganciclovir activity is due to inhibition of viral DNA synthesis by ganciclovir triphosphate."
Ganciclovir
"Ganciclovir is a synthetic analogue of 2'-deoxyguanosine, it inhibits replication of cytomegalovirus.~In CMV-infected cells it's phosphorylated (phosphorylation is dependent on the viral kinase and occurs preferentially in virus-infected cells). Ganciclovir activity is due to inhibition of viral DNA synthesis by ganciclovir triphosphate."
Hospital Univesitario Reina Sofía, Córdoba
Hospital Universitario de A Coruña, A Coruña
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario Puerta de Hierro, Majadahonda
Hospital Universitario Marques de Valdecilla, Santander
Hospital Universitario La Fe, Valencia
Hospital Universitario Vall D'Hebron, Barcelona
Instituto de Salud Carlos III
OTHER_GOV
Maimónides Biomedical Research Institute of Córdoba
OTHER